+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Impact of the trade-related aspects of intellectual property rights (TRIPS) agreement on India as a supplier of generic antiretrovirals



Impact of the trade-related aspects of intellectual property rights (TRIPS) agreement on India as a supplier of generic antiretrovirals



Journal of Pharmaceutical Sciences 100(3): 816-821



This is a commentary on how the trade-related aspects of intellectual property rights (TRIPS) agreement has impacted India as a supplier of generic antiretrovirals (ARVs). We provide a systematic review of the issues related to the TRIPS agreement that affects India. This includes discussion around (a) the legal landscape underpinning India as a supplier of generic ARVs; (b) supply of second-line ARVs; and (c) the future of generic drug production in India. The proclamation into force of TRIPS-compliant intellectual property law in India is likely to affect its position as a supplier of affordable ARVs, especially drugs brought to market after 2005. Currently, mechanisms exist for the generic production of almost all ARVs in India, including second-line drugs; however, the manufacture of these drugs by generic pharmaceutical companies may require additional market incentives. Compulsory licensing may emerge as an additional mechanism by which India can provide affordable versions of patented drugs to Least Developed Countries (LDCs).

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 053726212

Download citation: RISBibTeXText

PMID: 20740678

DOI: 10.1002/jps.22326


Related references

China's intellectual property protection strength and its evaluation - based on the accession to TRIPS Agreement (Agreement On Trade-related Aspects of Intellectual Property Rights). R&d Management 45(4): 397-410, 2015

Addressing legal and political barriers to global pharmaceutical access: options for remedying the impact of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) and the imposition of TRIPS-plus standards. Health Economics Policy and Law 3(Pt 3): 229-256, 2008

Flexibilities provided by the Agreement on Trade-Related Aspects of Intellectual Property Rights. Bulletin of the World Health Organization 96(3): 148, 2018

Trade Related Aspects of Intellectual Property Rights (TRIPS) and the threat to patients: a plea for doctors to respond internationally. Medicine and Law 17(3): 299-310, 1998

Medicine procurement and the use of flexibilities in the Agreement on Trade-Related Aspects of Intellectual Property Rights, 2001-2016. Bulletin of the World Health Organization 96(3): 185-193, 2018

Key questions for decision-makers. Protection of plant varieties under the WTO agreement on Trade-related Aspects of Intellectual Property Rights. Key questions for decision makers Protection of plant varieties under the WTO agreement on Trade related Aspects of Intellectual Property Rights: 23 pp., 1999

Public healthoriented intellectual property and trade policies in Africa and the regional mechanism under Trade-Related Aspects of Intellectual Property Rights amendment. Public Health 173: 1-4, 2019

Indian Patent Act 1970 and Trade Related Intellectual Property (TRIPs) Rights. Two and a Bud 2000; 46(1): 6-8, 1999

Institutions and Capacity Building for the Evolution of Intellectual Property Rights Regime in India: V - Analysis of Review of TRIPS Agreement and R&D Prospect in Indian Agriculture under IPR Regime. Journal of Intellectual Property Rights 13(5): 536-547, 2008

Access to generic antiretrovirals: inequality, intellectual property law, and international trade agreements. Cadernos de Saude Publica 23(Suppl. 1): S85-S96, 2007

Intellectual property rights, compulsory licensing and the TRIPS agreement: some ethical issues. Monash Bioethics Review 22(2): 63-68, 2003

Essential medicines and the TRIPS Agreement: collision between the right to health and intellectual property rights. Salud Colectiva 11(1): 9, 2015

The impact of trade related intellectual property rights. The impact of trade related intellectual property rights: 48 pp., 1996

Addressing legal and political barriers to global pharmaceutical access: options for remedying the impact of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) and the imposition of TRIPS-plus standards. Progress in Development Studies 2(1): 69-70, 2002

The economics of intellectual property rights under imperfect enforcement: developing countries, biotechnology, and the TRIPs agreement. EPTD Discussion Paper Environment and Production Technology Division, International Food Policy Research Institute (80): 40 pp., 2001